FAES Farma and Invida (a Menarini Group Company) Announce Agreement to Commercialize Bilastine in 17 Markets in Asia – Pacific

MADRID & SINGAPORE--(BUSINESS WIRE)--FAES FARMA, a leading Spanish pharmaceutical group dedicated to research, development, manufacturing and marketing of pharmaceuticals, and INVIDA Holdings Private Limited, a Member of the MENARINI Group and leading specialty biopharmaceutical company focused on the Asia Pacific region, are pleased to announce the signing of an exclusive long-term agreement to commercialize bilastine in 17 markets in Asia Pacific.